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Abstract
Background: Conventional periodontal therapy aims at controlling supra- and subgingival biofilms. Although
periodontal therapy was shown to improve periodontal health, it does not completely arrest the disease. Almost
all subjects compliant with periodontal maintenance continue to experience progressive clinical attachment loss
and a fraction of them loses teeth. An oral microbial transplant may be a new alternative for treating periodontitis
(inspired by fecal transplant). First, it must be established that microbiomes of oral health and periodontitis are
distinct. In that case, the health-associated microbiome could be introduced into the oral cavity of periodontitis
patients. This relates to the goals of our study: (i) to assess if microbial communities of the entire oral cavity of
subjects with periodontitis were different from or oral health contrasted by microbiotas of caries and edentulism
patients; (ii) to test in vitro if safe concentration of sodium hypochlorite could be used for initial eradication of the
original oral microbiota followed by a safe neutralization of the hypochlorite prior transplantation.
Methods: Sixteen systemically healthy white adults with clinical signs of one of the following oral conditions
were enrolled: periodontitis, established caries, edentulism, and oral health. Oral biofilm samples were collected
from sub- and supra-gingival sites, and oral mucosae. DNA was extracted and 16S rRNA genes were amplified.
Amplicons from the same patient were pooled, sequenced and quantified. Volunteer’s oral plaque was treated
with saline, 16 mM NaOCl and NaOCl neutralized by ascorbate buffer followed by plating on blood agar.
Results: Ordination plots of rRNA gene abundances revealed distinct groupings for the oral microbiomes of
subjects with periodontitis, edentulism, or oral health. The oral microbiome in subjects with periodontitis showed
the greatest diversity harboring 29 bacterial species at significantly higher abundance compared to subjects with
the other assessed conditions. Healthy subjects had significantly higher abundance in 10 microbial species
compared to the other conditions. NaOCl showed strong antimicrobial properties; nontoxic ascorbate was
capable of neutralizing the hypochlorite.
Conclusions: Distinct oral microbial signatures were found in subjects with periodontitis, edentulism, or oral
health. This finding opens up a potential for a new therapy, whereby a health-related entire oral microbial
community would be transplanted to the diseased patient.
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Background
The human oral microbiome is composed of a wide var-
iety of microorganisms that play important roles in health
and disease. Bacteria, for example, maintain oral and sys-
temic health [1], but can also cause disease. Bacterio-
phages shape microbial diversity [2]. Protozoans and fungi
consume food debris and other microbes [3, 4] and ar-
chaea utilize fermentation byproducts to produce methane
[5]. Yet, in terms of microbial species, our current under-
standing of the human oral microbiome is limited to a few
well-studied microorganisms. Based on what is known
about these microbes, researchers have developed concep-
tual models with the explicit purpose of determining the
etiology of oral diseases (e.g., [6, 7]). These models suggest
putative interactions among the microorganisms as well
as between microorganisms and the host. Although
these studies have significantly advanced the field, recent
studies show that the oral cavity is a complex and dy-
namic habitat consisting of hundreds of different inter-
acting species [8, 9].
The conceptual model for periodontitis is that Porphyro-
monas gingivalis, Tannerella forsythia, Treponema denticola
and Aggregatibacter actinomycetemcomitans are responsible
for the disease [6, 10, 11]. Evidence from animal models
indicated that these bacteria may disrupt tissue homeostasis
by manipulating signaling pathways of the host and once
the innate immunity is compromised, cause a shift in the
relative abundance of microbes, resulting in inflammation
and bone loss [12, 13]. Yet, it is well established that these
bacteria i.e., P. gingivalis, T. forsythia, T. denticola, A. acti-
nomycetemcomitans, are also found in healthy oral cavities
(e.g., [14–19]). Moreover, P. gingivalis is not found in up to
half of the patients with chronic or aggressive periodontitis
[20]. The paradox of these microbes being present in both
health and disease questions the validity of the conceptual
underpinnings of the etiology of periodontitis, which invites
for alternative ways of thinking about periodontitis as well
as other oral diseases.
Conventional periodontal therapies aim at controlling
supra- and subgingival biofilms and managing prognostic
factors such as poor glycemic control in subjects with dia-
betes mellitus and active smoking [21, 22]. Although peri-
odontal therapy has been shown to improve periodontal
health and reduce the rate of further clinical attachment
loss [23, 24] and tooth loss due to periodontitis [25–27], it
falls short of completely arresting the disease. Almost all
subjects compliant with periodontal maintenance care
continue to show signs of progressive clinical attachment
loss, and one- to two- thirds of them, lose one or more
teeth during an extended period of periodontal mainten-
ance care [28, 29]. We believe new thinking is necessary
for finding successful ways of treating periodontitis.
The knowledge from a different field indicates that an
appropriate microbial community is a key for maintaining
resistance against infection. A classic example is the gut
microbiome, which protects the host from Clostridium
difficile (CD) infection. Specifically, some patients develop
CD colonization of their gut upon antibiotic treatment,
which eradicates out their innate microbiome. A success-
ful strategy for combating CD by transplanting gut micro-
biota from a healthy donor was first medically recorded
more than 50 years ago [30]. (The origins of the procedure
date back to the 4th century in China [31]). Specifically, a
suspension of stool taken from a systemically healthy
intimate partner, relative or friend is introduced into the
gastrointestinal tract of the recipient via colonoscopy,
enema or a nasogastric tube. Recent systematic review re-
ports approx 90 % efficiency of eradicating the CD infec-
tion by a fecal transplant [32]. Besides the CD infection,
other potentially dysbiotic diseases were found to be
responsive to the microbial transplantation, such as in-
flammatory bowel disease, obesity. For a review on current
developments in the gut microbial transplant see Kelly
et al. [33].
Inspired by the success of the fecal transplant, here we
put forward a concept of a microbial transplant as a
potential therapy for periodontitis. We envision the ther-
apy of consisting of three steps: (i) harvesting sub- and
supra-gingival microbiota from a healthy donor, e.g.,
spouse or a partner; (ii), performing deep cleaning, root
planning and applying a broad-spectrum antimicrobial
agent to the periodontitis patient; and (iii) neutralizing
the antimicrobial agent immediately following by a rins-
ing with a microbial suspension harvested from the
healthy donor in the periodontitis patient.
The objectives of the present study were two-fold. The
first objective was to assess if the entire oral microbial
community of periodontitis was different from estab-
lished caries, edentulism, and oral health. The second
objective was to test an approach for applying a broad-
spectrum safe antimicrobial agent (NaOCl) to signifi-
cantly reduce the load of existing microbiome followed




Adult subjects were recruited at the Department of Peri-
odontics, University of Washington, Seattle, WA, U.S.A.
and Section of Periodontics, University of Düsseldorf,
Germany. A written informed consent for participation
in the study was obtained from the subjects. The study
was approved by the University of Washington Institu-
tional Review Board, ref. number 3570. Subjects were
enrolled if they had one of the following clinical condi-
tions: severe periodontitis, caries, edentulism, or oral
health. A periodontitis case was defined as having at
least 2 interproximal sites at different teeth with clinical
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attachment loss (CAL) of 6 mm or greater and at least 1
interproximal site with probing depth (PD) of 5 mm or
greater [34] and a minimum of 20 permanent teeth, not
including 3rd molars. Subjects were excluded from the
periodontitis group if they had multiple established car-
ies lesion or wore a removable partial denture. A caries
case was defined as having the following number of
teeth with established caries lesions: 6 or more teeth in
subjects 20 to 34 years of age; 4 or more teeth in sub-
jects 35 to 49 years of age; and 3 or more teeth in sub-
jects 50 years of age and older. Established caries was
defined as a class 4 lesion according to the International
Caries Detection and Assessment System. The number
of teeth with caries lesion in caries cases was greater
than one standard deviation above the mean of caries
extent in respective age group the U.S.A. [35]. Exclusion
criteria for a caries case were interproximal sites with
CAL of 4 mm or greater or PD of 5 mm or greater [34].
An edentulous case had to be completely edentulous in
both jaws and their teeth had to be extracted more than
one year before the enrollment in the study. A healthy
case was defined as having 28 teeth, not counting 3rd
molars, or 24 or more teeth, not counting 3rd molars if
premolars had been extracted for orthodontic reasons or
were congenitally missing with no signs of oral disease.
Exclusion criteria for a healthy case included: smoking,
loss of permanent teeth due to caries or periodontitis,
any interproximal sites with CAL of 4 or greater or PD
of 5 mm or greater, or any established caries lesions.
Exclusioncriteria for all groups included: oral mucosal
lesions, systemic diseases, and use of antibiotics or local
antiseptics within 3 months prior to the study.
Sample collection
For all but the edentulous patients, supra- and subgingi-
val plaque was collected from six sites with the deepest
probing depth in each sextant. One sterile paper point
per site was inserted into the deepest aspect of the peri-
odontal pocket or gingival sulcus. Biofilm from oral
mucosae was collected by swiping a sterile cotton swab
over the epithelial surfaces of the lip, left and right buc-
cal mucosae, palate, and dorsum of the tongue [36].
Samples were stored at −80 °C.
Molecular methods
Microbial DNA was isolated from cells by physical and
chemical disruption using zirconia/silica beads and
phenol-chloroform extraction in a FastPrep-24 bead
beater [37]. Prokaryotic 16S rRNA genes were amplified
using universal primers (27 F and 1392R) using the
GemTaq kit from MGQuest (Cat# EP012). The PCR
program involved a pre-amplification step of 10 cycles
with annealing temperature of 56 °C followed by 20
amplification cycles with annealing temperature 58 °C.
In each cycle, elongation time was 1 min 10s, at 72 °C.
PCR was finalized by extended elongation for 5 min.
PCR products were purified with DNA Clean & Concen-
trator columns (Zymo Research, USA) and quantified
using the NanoDrop (Agilent, USA).
Due to technical reasons, for some subjects, subgingi-
val and mucosal microbiotas were pooled together into
one vial, while for other subjects the subgingival and
mucosal microbiotas were stored separately. Since our
goal was to investigate the entire microbial community,
for the separately stored supra and subgingival micro-
biota samples, equal quantities of PCR product derived
from swab and paper point samples were pooled
together for each patient. For edentulous patients, there
were no paper point samples. Each purified PCR prod-
uct, 500 ng, was labeled with a Multiplex Identifier
(MID) during the Roche Rapid Library preparation step.
Four MID-tagged sequences, representing each of the
conditions, were combined in equimolar concentrations
and subjected to emPCR and DNA sequencing protocols
as specified by the manufacturer’s recommendations for
the Roche 454 Jr. instrument.
Data analysis
The obtained sequences were separated out by their re-
spective Multiplex Identifier (MID) and uploaded to the
MG-RAST web server [38]. The MG-RAST pipeline
assessed the quality of sequences, removed short se-
quences (multiplication of standard deviation of length
cutoff of 2.0) and removed sequences with ambiguous
bp (non-ACGT; maximum allowed number of ambigu-
ous base pair was set to 5). The pipeline annotated the
sequences and allowed the integration of the data with
previous metagenomic and genomic samples. The RDP
database was used as annotation source, with minimum
sequence identity of 97 %, maximum e-value cutoff at
10−5, and minimum sequence length of 100 bases. Alpha
diversity analysis was conducted in MG-RAST.
Orthogonal transformation of the annotated rRNA
genes to their principal components (PC) was conducted
using normalized abundances [39, 40]. Normalization of
the abundance was performed identically to the proced-
ure used by MG-RAST. Specifically, abundances were
increased by one, log2 transformed, and centered to pro-
duce relative values. Relative values were standardized
by dividing them by the standard deviation of the log2
values [38]. The data were graphed on a 2 dimensional
ordination plot. To determine the relative contribution
of the microbial species to the plot, we let X denote the
16 by 578 (patients by species) matrix of the normalized
abundance values. The matrix X was used to produce a
16 × 16 matrix D of distances between all pairs of sub-
jects. Principal coordinate analysis (PCoA, i.e., multidi-
mensional scaling) was achieved by performing principal
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component analysis (PCA) on the matrix of distances,
D. The Euclidean distance metric was used to create this
matrix, but this metric produced results similar to those
when the alternative Bray-Curtis distance was used. To
investigate and visualize differences between the four
patient groups, the first two principal components, PC1
and PC2, of the distance matrix D were retained. To
establish which species were most prominently respon-
sible for the groupings, the projection of each species
onto the (PC1, PC2) plane was calculated; those species
with the largest projections are displayed in the right
panel of Fig. 3. That is, this figure shows a biplot of the
species most highly correlated PC1 and PC2.
Mann–Whitney test (alpha = 0.05) was used to investi-
gate significant difference in normalized relative abun-
dances. The abundance data were normalized in two
different ways: MG-RAST normalization as described
above and raw abundances normalized to the total num-
ber of reads in a sample. Differences in alpha diversities
by condition were determined using ANOVA. Two-
tailed T-tests, assuming unequal variance, were used
investigate if there was significantly different in the
means (alpha = 0.05). These analyses were performed
using SAS JMP.
Sodium hypochlorite experiments
According to previously suggested concentration [41],
sodium hypochlorite experiments were conducted with
a 1:50 dilution of the 6 % household bleach (Chlorox,
The Clorox Company, USA), the “hypochlorite working
solution”. The dilution corresponds to 16 mM NaOCl.
The neutralizing agent was a sodium ascorbate buffer
produced by adjusting pH of a 23 mM ascorbic acid so-
lution with concentrated NaOH until pH 5.3.
Three samples of dental plaque from a volunteer was
subjected to three challenges: (i) resuspension in saline,
(ii) resuspension in the hypochlorite working solution
and (iii) resuspension in the hypochlorite working solu-
tion that was previously neutralized with equal volume
of the ascorbate buffer. Resuspended plaque samples
were plated on blood agar plates.
Active chlorine concentration was crudely assessed by
iodine colorimetry. A colorimetric solution contained 1
volume of 0.1 % stabilized starch solution (Fisher Scien-
tific) mixed with 0.1 volume of 1 M potassium iodide.
Two volumes of the colorimetric solution were mixed
with 1 volume of the solution containing NaOCl. Intense
blue color indicated detectable active chlorine. Iodine
colorimetry was calibrated with a dilution series of the
hypochlorite working solution with the following dilu-
tions 1:200, 1:400, 1:800, 1:1600, 0. The dilution1:800




A total of 16 subjects, 4 subjects with each of the
assessed oral conditions, were enrolled into the study.
Ten subjects were from Germany and 6 from the U.S.A.;
9 were females and 7 males. The age of the enrolled sub-
jects ranged from 28 to 92 years. Subjects with peri-
odontitis had a median of 34 sites (range 15 to 48) with
PD of 4 to 6 mm and 5 sites (range 4 to 26) with PD of
7 mm or greater while none of the subjects with caries
and none of the healthy subjects had any sites with PD
of 4 mm or greater. Subjects with caries had a median of
14 teeth (range 9 to 17) with established caries while
periodontitis and healthy subjects were mostly caries
free (Table 1).
Microbial signatures
The average (± std) number of 16S rRNA amplicons
sequences per individual oral microbiota was 13,104 ±
5,533 (Additional file 1: Table S1). The length and GC
content of the sequences was similar for all individuals:
514 ± 10 bp and 53 ± 1 bp, respectively. Comparison of
the number of sequences, sequence length, or GC con-
tent revealed no significant differences by oral condition
or gender, indicating a balanced data set. The rarefaction
curve of most samples approached saturation, indicating
sufficient reads for comparisons by condition and gender
(Fig. 1).
Alpha diversity of the oral microbiome in periodontitis
subjects was significantly (p < 0.05) greater compared to
that found in subjects with caries and edentulous sub-
jects. Although the oral microbiome was more diverse in
periodontitis subjects compared to healthy subjects, the
difference missed statistical significance (p = 0.06) (Fig. 2).
The composition of the oral microbiome in subjects
with periodontitis was distinctly different from that of all
other oral conditions. Specifically, the periodontitis con-
dition had greater abundances of Bacteroidetes (32 %),
Table 1 Demographics of the patients population
Condition
Parameter Healthy Periodontitis Caries Edentulous
America/Europe 0/4 2/2 2/2 2/2
Male/Female 2/2 2/2 2/2 1/3
Ages 41 (31–52)a 47 (28–58) 39 (29–49) 77 (58–92)
Number of teeth 27 (25–28) 28 (22–30) 28 (22–31) 0
ICDAS≥ 4 0 0 (0–1) 14 (9–17) –
PD≤ 3 mm 100 62 (26–79) 100 –
PD 4–6 mm 0 34 (15–48) 0 –
PD≥ 7 mm 0 5 (4–26) 0 –
ICDAS International Caries Detection and Assessment System, 4 denotes
established decay (dentine shadow), PD pocket depth
aMedian (min-max)
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Fusobacteria (7 %), Spirochaetes (5 %) and Synergisetes
(1 %) and fewer Actinobacteria (14 %) (Fig. 3). Actino-
bacteria were most abundant in the oral microbiome of
healthy (28 %) and edentulous subjects (34 %), followed
by Firmicutes, which occurred in abundances of 22 %
and 30 %, respectively (Fig. 3). Subjects with caries
showed somewhat lower abundances of Actinobacteria
(19 % vs. 29 %) and slightly greater abundances of Fuso-
bacteria (5 % vs. 3 %) in the oral microbial communities
compared to healthy subjects (Fig. 3).
“The red complex”
An ordination plot based on the 16S rRNA genes re-
vealed that the oral microbiomes in subjects with peri-
odontitis, edentulism, or oral health formed distinct
groups (Fig. 4, left panel). The ordination plot explained
78 % of the observed variability. These results, along
with the high diversity values, suggest that oral micro-
biome in subjects with periodontitis, edentulous subjects,
and healthy subjects were very different from each other.
Permutation MANOVA (pseudo F test, refs. [42, 43])
showed significant differences in microbial species abun-
dances between the four oral conditions (Bonferroni-
adjusted p-value of 0.0083). The Bonferroni adjustment
refers to the 6 comparisons, i.e., all pairs of the 4 groups.
In order to determine if the “red complex” bacteria (P.
gingivalis, T. denticola and T. forsythia) were absolute de-
terminants for the microbial signature of periodontitis, the
abundances of these organisms were removed from the
original data set. Non-parametric MANOVA and ordin-
ation plot analyses of the data set without “red complex”
bacteria did not alter the findings shown in Fig. 4a or the
p-value.
Projecting the top 23 contributing bacteria on the
PCoA plot (i.e., biplot) shows the relative contribution
of bacteria to the ordination (Fig. 4, right). Since the
purpose of the biplot was predominantly illustrative, the
number of displayed species, 23, was chosen arbitrary
based on the upper tail of the histogram of projection
sizes (Additional file 1: Figure S1). P. endodontalis,
Prevotella intermedia, T. vincentii, and an uncultured
Porphyromonas sp. were found to contribute to the mi-
crobial composition in periodontitis while a complex of P.
melaninogenica, Fusobacterium nucleatum, P. catoniae,
Capnocytophaga ochracea and C. sputigena, C. gingivalis,
Haemophilus parainfluenzae and Neisseria elongata con-
tributed to the microbial composition of orally healthy
subjects. Members of the Streptococcus and Lactobacillus
were associated with edentulism.
The species contributing to the differences in diversity
and the groupings in the ordination plot are shown in
Table 2. Twenty-nine out of the 587 microbial species
had higher abundances in patients with periodontitis
than those in the other assessed conditions. In the
healthy subjects, 10 out of the 587 microbial species
were found in higher abundances compared to the non-
healthy subjects (Table 3).
Antimicrobial agent and its neutralization
Antimicrobial activity of sodium hypochlorite was tested
with a volunteer’s dental plaque. Resuspension of the
plaque in 1:50 dilution of the household bleach, i.e., “the
hypochlorite working solution” resulted in a complete
inhibition of bacterial growth on a blood agar. In con-
trast, the viability of whole dental plaque bacteria was
maintained following exposure to the hypochlorite work-
ing solution inactivated for 7 min with 23 mM sodium
ascorbate buffer (Fig. 5). Starch-iodine colorimetry assay
revealed that sodium ascorbate - ascorbic acid buffer
reduced the concentration of active chlorine by a factor
of at least 800–1600, i.e., below 10–20 uM, after 30 s of
inactivation.
Fig. 1 Rarefaction curves obtained using RDP database with 97 %
similarity, 100 bp minimum alignment and e-value of 10−5. See Table 2
for labels
Fig. 2 Microbial species diversity differences among four oral
conditions. Shown are raw data, mean and standard deviation.
(*p = 0.06, **p < 0.05, ***p < 0.001, T-test)
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Discussion
Potential for the periodontitis bacteriotherapy
The first step towards developing a bacteriotherapy
for periodontitis is to establish the existence of a mi-
crobial community characteristic of periodontitis as
well as the community characteristic of oral health.
Two additional communities from edentulous and caries
patients, whose microbial communities are expected to be
distinct, were added for contrasting purposes.
Several studies have compared microbial communi-
ties isolated from different sites in the oral cavity and
from patients with different clinical conditions (e.g.,
[14, 15, 17, 19, 44–47]). One of these studies revealed
distinct partitioning of bacterial communities in subgingi-
val biofilms from healthy and diseased periodontal sites
[45]. Another study indicated that not only the oral
microbial species were drastically different between peri-
odontal health and disease but also their gene expression
[48]. Moreover, in subjects with periodontitis, disease-
associated bacteria were found on the buccal mucosae,
tongue, and saliva indicating that the entire oral micro-
biome might be altered [49–53].
Since the bacteriotherapy would likely be performed
by attempting to transplant both sub- and supra-
gingival microbes, the present study was set to test the
hypothesis that overall compositions of the oral micro-
bial communities were distinct between the conditions
of periodontitis, edentulism, caries, and oral health. In
fact, the entire oral microbiome of each subject was
obtained by pooling together several oral cavity sub-
microbiomes such as subgingival, supragingival, and
mucosal membranes.
Fig. 3 Percent abundance of microbes by phylum and condition
Fig. 4 Left panel: PCoA ordination plot of the 16 human oral samples by condition. Condition: red, periodontitis; blue, caries; black, edentulous;
green, healthy. Right panel: Projection of major microbial species contributing to the groups
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The key finding of this study, critically important for
the potential bacteriotherapy, is that microbial composi-
tions (i.e., signatures) of the entire (or substantial subset
of ) oral microbiomes of subjects with periodontitis con-
trasted by edentulism and oral health are distinct. In
addition, the microorganisms which are usually consid-
ered as pathogens of periodontitis, P. gingivalis, T. denti-
cola and T. forsythia, are not the sole representatives
of the periodontitis microbial signature. In particular,
this study provides evidence that a broad microbial-
community model of oral health may offer a valuable
perspective when considered in conjunction with (or
in contrast to) more common single-pathogen models ([7]
and refs. therein). With this perspective, it is reasonable to
expect that microbial community composition is a func-
tion of interspecies competition and cooperation, which
provides optimism for further developing the bacteriother-
apy. Below, we expand on the motivation for choosing
molecular methods and sampling procedures.
Methodological validity
Historically, subgingival oral microbiome was predomin-
antly assessed by a checkerboard hybridization technique
revealing signals from approx. 40 species (for review, see
[54]). Pathogenicity of a few species, i.e., “colored com-
plexes”, was presumed to account for oral conditions,
such as periodontitis. With the advent of next gener-
ation sequencing, extensive cataloging of the subgingival
Table 2 Bacterial species that had significantly different abundances (%) between individuals with the non-periodontitis (NP; e.g.,
healthy, caries, edentulous) and periodontitis (P) abundances based on Mann–Whitney test (alpha = 0.05)
Phylum/class Genus/species NP P
Actinobacteria Atopobium vaginae 0.01 0.35*
Actinomyces georgiae 0.05 0.35**
Actinomyces meyeri 0.10 0.49**
Bacteroidetes Porphyromonas endodontalis 0.12 2.91*
uncultured Porphyromonas sp. 0.04 1.26*
Porphyromonas gingivicanis 0.00 0.04**
Tannerella forsythia 0.20 0.83*
Prevotella intermedia 0.12 3.23*
Prevotella pallens 0.14 0.85*
Prevotella pleuritidis 0.00 0.01**
Prevotella salivae 0.20 0.74**
Firmicutes/Clostridia Parvimonas micra 0.12 1.19*
Eubacterium saburreum 0.07 0.28*
Pseudobutyrivibrio xylanivorans 0.00 0.06*
Peptostreptococcus anaerobius 0.07 0.50*
Firmicutes/Negativicutes Megasphaera micronuciformis 0.12 0.92*
Fusobacteria Leptotrichia wadei 0.10 0.32**
Proteobacteria/Deltaproteobacteria uncultured Desulfobulbus sp. 0.00 0.02*
Proteobacteria/Epsilonproteobacteria Campylobacter rectus 0.03 0.14*
Campylobacter concisus 0.03 0.07**
Spirochaetes/Spirochaetales Treponema denticola 0.07 1.60*
Treponema maltophilum 0.01 0.25*
Treponema medium 0.03 0.29*
Treponema socranskii 0.05 0.21*
Treponema sp. 0.03 0.10*
Treponema vincentii 0.07 0.71*
Treponema pectinovorum 0.00 0.04**
Synergistetes Synergistetes bacterium SGP1 0.05 0.23*
Aminobacterium colombiense 0.01 0.05*
*Significant difference using both normalization methods (i.e., raw species abundances were log2 transformed, normalized to produce relative values ((raw values-
average)/std) versus abundances normalized to the total number of reads in a sample)
**Significant difference for abundances using data normalized only to the total number of reads in a sample
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microbiome has been conducted (e.g., [17, 45, 55]). In
our study we also utilized high-throughput sequencing
technology, because it provides an in-depth qualitative
and quantitative characterization of the microbial com-
munities, which is essential for discovery of microbial
signatures.
The data for the analysis of microbial signatures
were the relative abundances of microorganisms mea-
sured by the number of sequencing reads obtained
from high-throughput sequencing of each subject’s
oral microbiome. Contrary to what one might expect, it is
important to note, that absolute abundances are not
attainable by the high throughput sequencing due to the
biases in amplification and other physicochemical reasons
[56, 57]. After sequencing reads are processed, each sub-
ject is represented by a p-dimensional vector (p = 597) in
the multidimensional space, with each coordinate corre-
sponding to the relative abundance of each microbial spe-
cies. The ordination analysis [58] presented in the Results
section is a standard dimension-reducing method, which
reveals the structure of the 3 groups (Fig. 4). Interpret-
ation of these groups is based on the subjects’ microbial
abundance profiles that are most similar and hence
grouped closer to each other. Although the sample size is
Table 3 Microbial species that had significantly different abundances (%) between individuals with the non-healthy (NH; periodontitis,
caries, edentulous) and healthy (H) abundances based on Mann–Whitney test (alpha = 0.05)
Phylum/class Genus/species NH H
Actinobacteria Micrococcus lylae 0.00 0.03**
Bacteroidetes Prevotella marshii 0.01 0.09**
Firmicutes/Bacilli Abiotrophia para-adiacens 0.22 0.60**
Granulicatella elegans 0.20 0.66*
Granulicatella adiacens 0.60 1.27**
Streptococcus iniae 0.04 0.15*
Firmicutes/Negativicutes Selenomonas ruminantium 0.00 0.10*
Proteobacteria/Betaproteobacteria Neisseria polysaccharea 0.00 0.02*
Proteobacteria/Gammaproteobacteria Aggregatibacter segnis 0.01 0.21**
Haemophilus parainfluenzae 0.17 0.46*
*Significant difference determined using both normalization methods (i.e., raw species abundances were log2 transformed, normalized to produce relative values
((raw values-average)/std) versus abundances normalized to the total number of reads in a sample)
**Significant difference for abundances using data that was normalized to only the total number of reads in a sample
Fig. 5 Dental plaque treated with saline, the hypochlorite working solution or inactivated hypochlorite working solution
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rather small (n = 16), the quality of the clusters and their
statistical significance (based on permutation) suggests
that the observed grouping may be reproducible in a lar-
ger, independent cohort. Other researchers, e.g., Kumar
et al. [47], showed with a larger group that there is a clear
separation between microbial communities for healthy
and periodontitis and peri-implantitis patients. Another
potential issue with generalization of our findings could
be due to the fact that all health subjects were from
Europe. Nevertheless, as was discovered by Nasidze et al.
[59], the compositions of the oral microbial communities
obtained from 12 worldwide locations of 10 individuals
each were “larger among individuals from the same loca-
tion than among individuals from different locations”.
Hence the differences in the composition among individ-
uals were not determined by geography.
Periodontitis pathogenesis: “red complex” or entire
community shift?
This study revealed grouping of subjects based on the
composition of their entire oral microbiomes, which is
consistent with previously reported results based on the
microbial composition of their subgingival plaque sam-
ples [47]. Specifically, it has been suggested that there
exist distinct microbial signatures characteristic of peri-
odontitis, peri-implantitis, and oral health. Our research
expands on these findings by investigating the entire oral
microbiome including combined together subgingival,
supragingival, and mucosal sub-microbiomes. Building
upon a recent report by Griffen et al. [45], which showed
a high microbial diversity of sub-gingival biofilms in sub-
jects with periodontitis compared to oral health, our
study also revealed a similarly increased diversity in the
entire oral microbiome of subjects with periodontitis
compared to edentulism, oral health and caries. Among
the four conditions, our study showed the lowest micro-
bial diversity in oral microbiomes of subjects with eden-
tulism. This is presumably due to the absence of teeth
and subgingival pockets in which otherwise mature bio-
films develop [45]. It is important to note that there are
other studies focused on microbial signatures of peri-
odontitis (e.g., [60]), however these studies did not
attempt to contrast several conditions.
Our observations support the polymicrobial nature of
periodontitis contrary to the “old-school” long-standing
notion of specific pathogens believed to cause periodon-
titis. Indeed, the oral microbial signature in periodontitis
subjects included P. gingivalis, T. denticola and T. for-
sythia, which are collectively referred to as the “red
complex”. As our results showed, red complex bacteria
were not the absolute determinants of the periodontitis
microbial signature. The presence of the red complex
bacteria in oral health and other conditions could be
attributed to differences in: (i) the host immune response,
(ii) genes encoding virulence factors among different
strains, and (iii) gene regulation [51]. The findings of dis-
tinct oral microbial signatures between subjects with peri-
odontitis and oral health supported the notion that
periodontitis is associated with a dysbiosis (i.e., microbial
imbalance) of the entire oral microbiome. The oral dysbio-
sis may be due to the assembly of a synergistic microbial
community that tilts the balance away from a health-
associated microbial homeostasis [51]. It could be initiated
by the acquisition of virulence factors by microbes and/or
changes in the regulation/expression of genes within the
community [17, 61]. Perhaps one or several microorgan-
isms, e.g., P. gingivalis, are capable of initiating synergetic
interactions that ultimately result in the emergence of
disease-provoking microbial community [7], however a
mechanistic proof is lacking.
The idea for the potential bacteriotherapy of periodon-
titis is inspired by the success of the fecal microbial
transplant treatment of Clostridium difficile (CD) infec-
tion. It should be noted that while the diversity of
bacteria associated with periodontal disease is very high
[55, 62], the diversity of bacteria associated with CD in-
fections is very low [63]. The reason to emphasize these
differences is that the goal of bacteriotherapy for CD is
to increase bacterial diversity whereas the goal of bacter-
iotherapy for periodontitis is not the same since the
bacterial diversity is already high. Presumably in both
diseases, replacement of healthy stable microbial com-
munities is the answer to prevent future dysbiosis. How-
ever, without performing actual experiments, one cannot
speculate on the success or failure of bacteriotherapy for
periodontal disease.
Antimicrobial treatment before the transplant
It is reasonable to assume that for the bacteriotherapy to
be successful, the recipient’s oral cavity has to have lowest
possible load of microorganisms to allow the new micro-
biome to flourish without interference from the previous
disease-associated microbiome. Administration of adjunct-
ive systemic antibiotics [64, 65] or a full-mouth disinfection
approach that reduces the bacterial reservoir in all habitats
of the oral cavity will result in more pronounced shifts in
the microbial composition and significantly reduces the in-
cidence of clinical attachment loss compared to supra- and
subgingival debridement alone [37, 66, 67]. Still, it is desir-
able to administer such an antimicrobial agent that is ef-
fective against a broad spectrum of microbes and is easy to
neutralize with another nontoxic agent, because as most
antiseptics remain active in the oral cavity for quite some
time [68, 69] and therefore, may affect the viability of an
oral microbial transplant. We have been able to demon-
strate that sodium hypochlorite (NaOCl), which is bac-
tericidal against a panel of oral biofilm microorganisms
[68, 70, 71], can be inactivated by a nontoxic sodium
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ascorbate – ascorbic acid buffer. Although some critics
have said that NaOCl treatment is antiquated and danger-
ous, a recent study proved the opposite [72]. Moreover,
the Galvan et al. study [72] showed safety and a significant
reduction of plaque and bleeding on probing in the group
that used NaOCl rinses compared to the control group.
Conclusions
The present exploratory study revealed statistically sig-
nificant microbial signatures of oral health and peri-
odontitis. This finding presents a path forward for a
potential new therapy for periodontitis, which could be
based on substituting periodontitis-associated micro-
biome with the health-associated one. At the beginning
(in 1950s), the fecal transplant therapy was successfully
used without a deep mechanistic understanding. Cur-
rently, insights into the gene expression and metabolic
effects of the therapy have been made (e.g., [73]). If the
proposed therapy is proven to be successful, deep mech-
anistic studies will be of great interest.
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